𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Methodological evaluation of a new chemiluminescence immunoassay for thyrotropin using acridinium ester-labelled antibody

✍ Scribed by Zucchelli, G. C. ;Pilo, A. ;Masini, S. ;Chiesa, M. R. ;Masi, A.


Publisher
John Wiley and Sons
Year
1989
Weight
395 KB
Volume
4
Category
Article
ISSN
0884-3996

No coin nor oath required. For personal study only.

✦ Synopsis


A recently available immunochemiluminometric assay (ICMA) for TSH developed by Ciba Corning Corp. has been evaluated. This system (Magic Lite) uses an acridinium-ester-labelled antibody and magnetizable particle for bound-free separation. In each assay only t w o calibrators are carried out and used to re-scale a manufacturer-generated curve stored in the memory of the luminometer. The precision of the response (RLU) estimated by all duplicates of 14 runs was about 4% for responses >12,000 RLU (corresponding t o a concentration interval 0.7-113pIU/ml) and worsened in the lower range (up t o 10% CV); the sensitivity, computed from the mean within-assay precision profile, was 0.028 plU/ml; the betweenassay precision ranged from 4.6 t o 13.1 CV%. Regression analysis of ICMA results ( y ) against consensus values of Behring IRMA (x) on 15 QC sera assayed in an inter-laboratory survey (concentration range 1 3 0 plU/ml) gave y = -0.003 + 0 . 9 8 ~ indicating a good agreement of the two techniques. Similar conclusions have been derived from the comparison of the ICMA results (y) in the low TSH concentration range (< 1 plU/ml) against the IRMA Boots Celltech (x) on 80 patient samples ( y = 0.04 + 1.04~).


📜 SIMILAR VOLUMES


Evaluation of a new commercial enzyme im
✍ Ryan J. Welch; Brian L. Anderson; Christine M. Litwin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract As West Nile virus (WNV) has become endemic in the United States, following the first reported cases in New York during the summer of 1999, the demand for specific serology has increased. Several IgM capture ELISA assays for the detection of WNV‐specific IgM have been approved by the Fo